| BG |
Report |
Adj. EPS |
BEAT |
pred ~$2.15 vs. cons $2.03 |
MEDIUM |
| BG |
Report |
Adj. segment EBIT |
BEAT |
pred ~$720M vs. cons ~$680M |
MEDIUM |
| BG |
Report |
Revenue |
IN-LINE |
pred ~$23.6B vs. cons $23.5B |
LOW |
| BG |
Guide |
FY26 adj. EPS guide |
BETTER |
guide ~$9.50-10.00 (mid ~$9.75) vs. cons ~$9.30 (FY26) |
MEDIUM |
| BG |
Guide |
Implied Q2 vs Street (cadence ~40% H1) |
UNKNOWN |
implied Q2 ~$1.85-1.90 vs. cons $2.03 (Q2'26) |
MEDIUM |
| BG |
Guide |
Viterra synergies |
BETTER |
~$190M+ FY26 tracking ahead vs. ~$190M plan (FY26) |
MEDIUM |
| BG |
Guide |
Below-the-line (interest + tax rate) |
LOWER |
interest ~$620-660M & tax 22-26% vs. Q1 ~18% (FY26 headwind) |
MEDIUM |
| BG |
Guide |
Buyback completion |
UNCHANGED |
remaining ~$250M by YE vs. ~$250M plan (FY26) |
LOW |
| BG |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.5% |
— |
MEDIUM |
| BG |
Return |
5-day cumulative residual |
+0.5% (FADE) |
Likely Q2 beat vs Street plus a modest FY guide-raise drives an initial pop, but the Street already models above Bunge's own ~40% H1 cadence and H2 crush curves remain heavily inverted with limited visibility; as analysts reconcile the beat against the implicitly lower H2 out-period math (tropicals softness, higher interest/tax, thin forward liquidity) and shares still sit well below the June ~$131 peak, the day-1 gain gives back most ground and stabilizes lower. |
MEDIUM |